Thank you so much for adding your two posts this morning...

Thank you so much for adding your two posts this morning ,Davybabyk .
For novices like myself in this science , and in respect to the "journey"of IMU , you are one of the shing lights to help get our heads around the great progress IMU is making .
It may well have been posted and referenced here before ...but the attached article provides some insightful knowledge , about this vast medical science market , and the role that the FDA plays in it :
https://www.fiercepharma.com/special-reports/2023-drug-approvals-after-down-year-fda-signs-bounty-new-medicinesThe edited subheading , demonstrates how much more active the FDA has become again in drug approval :

After signing off on 37 new drugs in 2022, its fewest since 2016, the FDA approved 55 in 2023, the second-most ever by the United States regulator. (Photo by Sarah Silbiger/Getty Images)The run down on the drug approval at the foot of the article ,,,makes eye opening reading .
Some others might get more out of the article ...and as it may apply to IMU going forward ,,as its FDA fast tracking proceeds into 2024 .

Another interesting snippet that comes within the article ..is an advert for a forthcoming Conference in San Francisco in early March ..where many/most of the BIG PHARMA's will again be in attendance :March11th and12th
https://www.bdlsummit.com/
What new information that IMU has available by then ..will be very , very interesting .
Hope this of some use to the general discussion .